{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-24-100971","form_type":"8-K","ticker":"NEUP","cik":"0001191070","company_name":"Neuphoria Therapeutics Inc.","filed_at":"2024-11-21T23:59:59+00:00","discovered_at":"2026-05-14T18:03:07.868269+00:00","generated_at":"2026-05-29T20:25:03.475597+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"confidence":"high","headline":"Bionomics enters $2M ATM offering with H.C. Wainwright, replaces prior $11.5M program","bullets":["Signed ATM agreement with H.C. Wainwright for up to $2 million in ADSs; 3.0% sales commission.","Prior $11.5M ATM program with Cantor Fitzgerald terminated before signing new agreement.","Shelf registration on Form S-3 filed Nov 18, 2024 (File No. 333-283306) for the offering.","Sales agent may sell ADSs on Nasdaq at market prices; no minimum required sales."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-24-100971","json":"https://secwatch.observer/filing/0001213900-24-100971.json","markdown":"https://secwatch.observer/filing/0001213900-24-100971.md","text":"https://secwatch.observer/filing/0001213900-24-100971.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1191070/000121390024100971/0001213900-24-100971-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1191070/000121390024100971/ea0221911-8k_bionom.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-29T20:25:03.475597+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}